Helius Medical Technologies (NASDAQ: HSDT) has successfully completed a PIPE financing round exceeding $500 million, led by Pantera Capital and Summer Capital. Notable participants include Animoca Brands and HashKey Capital. The financing is priced at $6.881 per share, with attached warrants exercisable at $10.134, potentially increasing the total to over $1.25 billion if fully exercised. The company plans to use the funds to launch its SOL Treasury strategy, positioning SOL as a primary reserve asset and exploring on-chain DeFi yield opportunities.
Helius Medical Technologies Secures Over $500 Million in PIPE Financing
Disclaimer: The content provided on Phemex News is for informational purposes only. We do not guarantee the quality, accuracy, or completeness of the information sourced from third-party articles. The content on this page does not constitute financial or investment advice. We strongly encourage you to conduct you own research and consult with a qualified financial advisor before making any investment decisions.